(2s,4r)-1-((s)-2-(7-(4-((r)-3-((4-(N-(4-(4-((4′-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoyl)sulfamoyl)-2-((trifluoromethyl)sulfonyl)phenyl)amino)-4-(phenylthio)butyl)piperazin-1-yl)-7-oxoheptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((s)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
(2s,4r)-1-((s)-2-(7-(4-((r)-3-((4-(N-(4-(4-((4′-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoyl)sulfamoyl)-2-((trifluoromethyl)sulfonyl)phenyl)amino)-4-(phenylthio)butyl)piperazin-1-yl)-7-oxoheptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((s)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
Product Specifications
CAS Number:
2365172-42-3
MDL Number:
Product Code:
ID:
A21570
Purity:
98%
Packaging:
| Product Number | A21570 |
| Name | (2s,4r)-1-((s)-2-(7-(4-((r)-3-((4-(N-(4-(4-((4'-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoyl)sulfamoyl)-2-((trifluoromethyl)sulfonyl)phenyl)amino)-4-(phenylthio)butyl)piperazin-1-yl)-7-oxoheptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((s)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide |
| CAS | 2365172-42-3 |
| MDL | |
| Purity | 98% |
| Concentration | |
| Packaging | |
| M.F | C77H96ClF3N10O10S4 |
| M.W | 1542.36 |
| Storage | Refrigerate, sealed, dry |
| Appearance | |
| Melting Point | |
| Boiling Point | |
| Density | |
| Flash Point | |
| Water Solubility | |
| Evapouration rate | |
| Vapour pressure | |
| Vapor Density | |
| Decomposition temperature | |
| Viscosity | |
| Sensitivity | |
| Explosive properties | |
| Oxidizing properties | |
| Incompatibilities | |
| Odour | |
| Odour Threshold | |
| SMILES | |
| InChICode | |
| InChIKey |
| GHS Symble | |
| Warning Words | |
| H-Code | |
| P-Code | |
| EINECS | |
| Hazard Codes(Europe) | |
| EU_Hazard_Risk_Phrases | |
| EU_Hazard_Safety_Phrases | |
| UN Number | |
| Transport hazard class(es) | |
| Packaging group |
| Acute Toxicity | |
| Skin corrosion/irritation | |
| Serious eye Damage/irritation | |
| Respiratory or skin sensitisation | |
| Germ Cell mutagenicity | |
| Carcinogenicity | |
| Reproductive toxicity | |
| STOT-single exposure | |
| STOT-repeated exposure | |
| Aspiration hazard |
| Purpose |